Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome

NCT03630367 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-04-23

No results posted yet for this study

Summary

The aim of the present study was to investigate the efficacy of L-carnitine therapy on the occurrence and prognosis of respiratory distress syndrome

Conditions

  • Premature Birth

Interventions

DRUG

Dexamethasone

Intramuscular injection 8 mg

DRUG

L-Carnitine 1G/5mL Injection

slow intravenous injection

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-03
Primary Completion
2020-09-30
Completion
2020-10-31

Countries

  • Egypt

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630367 on ClinicalTrials.gov